… obinutuzumab [Gazyva] or rituximab [Rituxan] as their next line [ … in the College of Medicine at The Ohio State … indicated by the FDA for the treatment of adult patients … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants-accelerated …

… ; M-Pola) compared with rituximab (Rituxan) plus gemcitabine and oxaliplatin (R … associate professor of medicine at The Warren Alpert Medical School of Brown … ] first-line treatment. This trial, [unlike] some other recently reported trials, enrolled high …

… of Medicine (Hematology) at Yale University. Transcript: The current treatment … changed among most lymphoma doctors. That is based off … we typically go for rituximab [Rituxan] and bendamustine [Treanda]- … , although we have clinical trials ongoing here, so we …

… adjusting for baseline characteristics between trials, investigators reported significantly prolonged PFS … of bendamustine (Treanda) plus rituximab (Rituxan) in arm B; those with … -label, phase 3 CLL14 trial assessed treatment with 12 cycles of chlorambucil …

… M-Pola) vs rituximab (Rituxan) plus gemcitabine and oxaliplatin (R … Regarding safety, the trial showed that treatment-related adverse events ( … least 5% between the treatment arms that were more … professor of medicine at The Warren Alpert Medical School of …

… Brief: An experimental drug from biotechnology company aTyr Pharma missed … nearly a year of treatment. The drug, called efzofitimod, is … use of other drugs like methotrexate or Rituxan. At the … highest dose tested in the clinical trial, …

… 3 BRUIN CLL-313 trial (NCT05023980) showed that … and rituximab (Rituxan; BR) in patients with treatment-naïve chronic … study [NCT05254743], at upcoming medical meetings and preparing global … the results of ongoing confirmatory trials. REFERENCES: 1. Lilly…

… trial (NCT05023980) that evaluated pirtobrutinib monotherapy vs bendamustine (Treanda) plus rituximab (Rituxan … with previously reported trials across various treatment settings. " … [NCT05254743], at upcoming medical meetings and preparing global …

… rituximab (Rituxan; BR) in patients with treatment-naive chronic … from previously reported trials across various treatment settings. Together, … trial, according to Eli Lilly and Company, the drug’ … study, at upcoming medical meetings and preparing global …

… lymphoma. When analyzing various treatment regimens for follicular lymphoma, … lenalidomide (Revlimid) and rituximab (Rituxan) combination. This is particularly … combination. Of the 3 drugs, lenalidomide is the … rituximab. In the clinical trial, the addition of …